Harliku Tablet
Product Images NDC 70709-112

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Harliku (NDC 70709-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cycle Pharmaceuticals Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Bottle Label)

HARLIKU (nitisinone) 2 mg tablets label showing 60 tablets per container. Marketed by Cycle Pharmaceuticals Ltd., UK, and manufactured by Rivopharm SA, Switzerland. The label includes storage instructions to keep at room temperature 20°C to 25°C, Rx only designation, and barcodes with NDC 70709-112-60.*

FDA Label Image

Principal Display Panel (Carton Label)

HARLIKU (nitisinone) tablets 2 mg oral medication packaging label shows the product name and strength prominently. The box contains 60 tablets and is labeled Rx only. Marketed by Cycle Pharmaceuticals Ltd and manufactured by PCI Pharma Services in the UK. Storage instructions specify room temperature between 20°C to 25°C with permitted excursions. The label includes inactive ingredients glyceryl dibehenate and lactose monohydrate, plus a barcode and contact information.*

FDA Label Image

Image Description (Cyclelogo)

FDA Label Image

Figure 1 Structural Formula (Structure)

Chemical structure of nitisinone, showing a bicyclic compound with carbonyl groups, a nitro substituent, and a trifluoromethyl group attached to an aromatic ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.